Compare Invesco NASDAQ 100 ETF (QQQM) vs GeneDx Holdings Corp (WGS) Price & Performance

Invesco NASDAQ 100 ETFTrade

GeneDx Holdings CorpTrade

Price performance (Past 24H)

Key statistics

Invesco NASDAQ 100 ETF vs GeneDx Holdings Corp — how do they compare? Invesco NASDAQ 100 ETF trades at $295.38, while GeneDx Holdings Corp trades at $86.53 (market cap $2.56B). The key difference: Invesco NASDAQ 100 ETF is trading nearer its 52-week high, GeneDx Holdings Corp nearer its low. Which is the better fit depends on your goals.

	QQQM	WGS
Sector	Broad Market / Factor	Technology
52-Week High	$307.23	$167.51
52-Week Low	$229.87	$34.51
Market Cap	—	$2.56B
Enterprise Value	—	$2.60B

View details →View details →

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Invesco NASDAQ 100 ETF

QQQM trades at $295.76, down 0.1% with a bullish technical signal from moving averages. The ETF tracks the Nasdaq-100 index, offering diversified exposure to large-cap growth stocks. Recent news highlights QQQM's low expense ratio advantage over QQQ and its position as a core growth allocation option for investors seeking Nasdaq-100 exposure.

The outlook remains positive for long-term growth investors, with technical indicators supporting bullish momentum. Key risks include concentration in top holdings and market sensitivity to technology sector performance. The ETF's low-cost structure provides a competitive advantage for sustained investment.

GeneDx Holdings Corp

WGS trades at $85.87, down 0.14% today, with a bullish technical signal from moving averages and support at $84. The company reported Q2 2026 revenue of $114.4M, beating estimates, and returned to adjusted profitability early. However, net income remains negative at -$106M for 2026, with high valuation multiples like EV/EBITDA of 161.17. Recent news highlights partnerships and product launches, such as the NPC GenomeComplete initiative with Beren Therapeutics.

Outlook is mixed: strong analyst buy consensus (90.9%) and institutional interest support upside, but profitability challenges and a class action lawsuit pose risks. Revenue growth and operational improvements are key catalysts, yet high debt-to-asset ratios and negative margins require monitoring for sustained recovery.

Aura AI is an analytical signal, not financial advice — do your own research.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

QQQM

TQQQ returned 59.18% vs. QQQ's 24.99%, but leverage costs and daily resets reduce its triple return over time.24/7 Wall Street · 12 hours agoNeutral SCHG preferred over QQQM for broader growth exposure and lower cost, while QQQM suits pure Nasdaq-100 focus.Seeking Alpha · 19 hours agoBullish QQQM ETF offers lower fees than QQQ, saving investors thousands over decades with identical Nasdaq-100 exposure.24/7 Wall Street · 1 day agoNeutral View details →

WGS

View details →

About Invesco NASDAQ 100 ETF

QQQM is an ETF designed to track the performance of the NASDAQ-100 Index. It provides exposure to the 100 largest non-financial companies listed on the NASDAQ. Positioned as a lower-cost and more long-term-investor-friendly alternative to its peer QQQ, QQQM offers the same fundamental market exposure but typically has a lower share price and is structured to appeal to investors focused on accumulation rather than active trading.

About GeneDx Holdings Corp

GeneDx is a patient-centered health intelligence company that specializes in transforming healthcare through the application of genomics. It combines advanced technology with one of the world's largest rare disease genomic datasets to provide clinical-grade exome and genome sequencing, enabling precise and rapid diagnosis for patients with complex medical conditions.